Sutro Biopharma, Inc 10-Q for FY2023 Q1
Sutro Biopharma, Inc. (STRO)
10-Q
2023-05-15
For: 2023-03-31
View Original
Added on
April 11, 2026
About this 10-Q
Sutro Biopharma, Inc filed this 10-Q on May 15, 2023, covering the quarter ended March 31, 2023 (FY2023 Q1).
Headline figures
Quarter ended March 31, 2023, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $12.67M
- up 114.9% from $5.9M a year earlier
- Net loss
- $50.05M
- compared with a net loss of $39.11M a year earlier
- Diluted EPS
- -$0.85
- compared with -$0.84 a year earlier